Načítá se...
Liposomal Nanostructures for Drug Delivery in Gastrointestinal Cancers
Gastrointestinal (GI) cancers like liver, pancreatic, colorectal, and gastric cancer remain some of the most difficult and aggressive cancers. Nanoparticles like liposomes had been approved in the clinic for cancer therapy dating as far back as 1995. Over the years, liposomal formulations have come...
Uloženo v:
| Vydáno v: | J Pharmacol Exp Ther |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The American Society for Pharmacology and Experimental Therapeutics
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6812858/ https://ncbi.nlm.nih.gov/pubmed/30541917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.118.254797 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|